|Day Low/High||18.61 / 19.64|
|52 Wk Low/High||9.00 / 25.97|
Just as we saw with pot stocks, if you play shares strictly because they're going up, you're likely to get burnt.
Ayr Strategies is expanding in a contracting market.
The amended deal between the two cannabis companies is a doozy.
I continue to recommend a reduced long exposure on STZ.
Publicly traded cannabis companies are expected to take big write downs on assets, and here's why it matters.
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.
If the Democrats sweep, you have perhaps the best single stock in the market.
Interpreting the flow of capital in theory, or at least historically, for equities is quite simple. It's about growth, or the lack thereof.
CGC has started to make its move to the upside, so let's see what the charts say and how to play this cannabis name.
The daily picture has my attention. The big watch here is the 50-day simple moving average.
There are 153,000 convenience stores in the U.S. and these outlets sell the bulk of the country's cigarettes.
Here's our latest trading strategy on STZ.
Here's how investors can trade the cannabis stock.
This six-pack from investment specialists includes a REIT and a software provider specializing in the industry.
With over $2.5 billion raised by SPACs in the cannabis industry, there is more buying power in the market that is fueling new M&A activity.
Put CGC on your potential shopping list and let's keep an eye on it.
As the president's press conference on China approaches, there is ample reason for some risk-off behavior. Meantime, Zscaler's earnings beat is a good time to take a profit.
That doesn't mean we'll move straight up over the summer, but we'll get plenty of virus, China, stimulus, cannabis, and unemployment chatter.
A look at some names that Robinhood brokerage CEO Tenev tells us young people are buying.
I think their sales are sustainable in part because we are scared to go to the supermarket but we know we have to because we can't go out much.
These companies initially seemed to believe that regulators and law enforcement would drive out the illicit market dealers. That hasn't happened.
Some businesses offer curbside delivery while others boost online sales -- still some can't escape closings and cut forecasts.
It's just plain cheaper to grow outside.
No matter what the current price to earnings multiple or enterprise to sales or even out year sales analysis, that sucker's going up.
Cannabis investors have been sorely disappointed in the stock's performance.
* Moving to small-sized in cannabis In the next week I hope to update my fundamental view and share price outlook on the cannabis space. I had expected the stocks to bounce in January, after the tax selling period of late 2019 abated. To some degree...
Canopy Growth continues to make a nice run this morning. Here is your "Marijuana Moment."
Canopy Growth is getting jiggy. Finally, back to break even (after buying - "the funnel" - at $14.60).
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Buyers of the beer and wine seller's shares have become more aggressive.